“…In the prophylaxis and treatment of acute gastroduodenal lesions, however, the advantages of cimetidine have only been suggested by the results of animal experiments [14, 86, I00], clinical case reports [6,24,75,94], retrospective trials and prospective trials using either historical controls [13,52,82,107] or patients from highly selected groups [25,26,30,42,76,112]. Since histamine H2-receptors in acid secretion [9] and microcirculation [41] and histamine release from intra-and extragastric cellular stores [64,65,105,106] are likely to play an important role in the pathogenesis of acute as well as chronic gastroduodenal ulceration it could be expected that therapy using H2-receptor antagonism could offer clinical advantages to patients likely to or developing stress ulcerations.…”